Back
Vertex Pharmaceuticals Vs. Q32 Bio Industry Stock Comparison
Buy
62
VRTX
Vertex Pharmaceuticals
Last Price:
485.46
Seasonality Move:
-1.44%
Sell
45
QTTB
Q32 Bio
Last Price:
46.10
Seasonality Move:
-18.39%
Buy
62
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $485.37. The Score for VRTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Q32 Bio (QTTB)
is a Sell
Is Q32 Bio a Buy, Sell or Hold?
- The current Q32 Bio [QTTB] share price is $46.15. The Score for QTTB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- QTTB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $485.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
QTTB Stock Price Chart
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.13 | Sell |
| Relative Strength Index (14 RSI): | 55.04 | Buy |
| Chaikin Money Flow: | 565555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (469.79 - 486.79) | Buy |
| Bollinger Bands (100): | (435.95 - 494.03) | Buy |
QTTB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.22 | Buy |
| Relative Strength Index (14 RSI): | 61.05 | Buy |
| Chaikin Money Flow: | 43454 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.54 - 44.72) | Buy |
| Bollinger Bands (100): | (21.2 - 38.56) | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 474.46 | Buy |
| 20-day SMA: | 480.66 | Buy |
| 50-day SMA: | 483.27 | Buy |
| 200-day SMA: | 437.3 | Buy |
| 8-day EMA: | 477.84 | Buy |
| 20-day EMA: | 478.82 | Buy |
| 50-day EMA: | 477.2 | Buy |
| 200-day EMA: | 439.16 | Buy |
QTTB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.69 | Buy |
| 20-day SMA: | 41.84 | Buy |
| 50-day SMA: | 35.85 | Buy |
| 200-day SMA: | 22.12 | Buy |
| 8-day EMA: | 45.44 | Buy |
| 20-day EMA: | 42.43 | Buy |
| 50-day EMA: | 36.87 | Buy |
| 200-day EMA: | 26.57 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $1.22 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
Q32 Bio Earnings Growth & QTTB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vertex Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Q32 Bio Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||